ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,215
Diagnostic referrals
999
Outstanding pathways
332

Screening pathway

  1. Screening5,215Encounters
  2. Positive finding1,814Documented findings
  3. Referral999Diagnostic referrals
  4. Follow-up1,211Diagnostic visits
  5. Outcome667Resolved pathways

Stage totals use different units. Pending pathways: 332. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2027-03-12, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3267 · Expanded synthetic participant 3267Site B — Peri-Urban Access Programme
EXP-3268 · Expanded synthetic participant 3268Site B — Peri-Urban Access Programme
EXP-3269 · Expanded synthetic participant 3269Site B — Peri-Urban Access Programme
EXP-3270 · Expanded synthetic participant 3270Site A — Urban Referral Hub
EXP-3271 · Expanded synthetic participant 3271Site B — Peri-Urban Access Programme
EXP-3273 · Expanded synthetic participant 3273Site D — Community Engagement Programme
EXP-3274 · Expanded synthetic participant 3274Site D — Community Engagement Programme
EXP-3275 · Expanded synthetic participant 3275Site B — Peri-Urban Access Programme
EXP-3276 · Expanded synthetic participant 3276Site E — Resource-Constrained Navigation Programme
EXP-3277 · Expanded synthetic participant 3277Site D — Community Engagement Programme
EXP-3278 · Expanded synthetic participant 3278Site B — Peri-Urban Access Programme
EXP-3281 · Expanded synthetic participant 3281Site B — Peri-Urban Access Programme
EXP-3282 · Expanded synthetic participant 3282Site C — Rural Outreach Programme
EXP-3283 · Expanded synthetic participant 3283Site A — Urban Referral Hub
EXP-3284 · Expanded synthetic participant 3284Site C — Rural Outreach Programme
EXP-3286 · Expanded synthetic participant 3286Site A — Urban Referral Hub
EXP-3287 · Expanded synthetic participant 3287Site D — Community Engagement Programme
EXP-3288 · Expanded synthetic participant 3288Site B — Peri-Urban Access Programme
EXP-3289 · Expanded synthetic participant 3289Site E — Resource-Constrained Navigation Programme
EXP-3290 · Expanded synthetic participant 3290Site B — Peri-Urban Access Programme
EXP-3291 · Expanded synthetic participant 3291Site D — Community Engagement Programme
EXP-3292 · Expanded synthetic participant 3292Site E — Resource-Constrained Navigation Programme
EXP-3293 · Expanded synthetic participant 3293Site C — Rural Outreach Programme
EXP-3294 · Expanded synthetic participant 3294Site D — Community Engagement Programme
EXP-3295 · Expanded synthetic participant 3295Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1957
HPV DNA
2539
Cytology
719

Navigation activity

Barrier documented
907
Contact attempt
1458
Navigation intervention
397
Diagnostic booking
1256
Diagnostic visit
1211

Documented barriers

Contact difficulty
291
Transport difficulty
299
Appointment coordination
317

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.